Arena Pharmaceuticals, Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2013-03-31 3 months ending 2012-12-31 3 months ending 2012-09-30 3 months ending 2012-06-30 3 months ending 2012-03-31
Revenue 2.37 1.94 1.49 21.98 2.19
Other Revenue, Total - - - - -
Total Revenue 2.37 1.94 1.49 21.98 2.19
Cost of Revenue, Total 2.12 0.83 1.40 0.65 0.79
Gross Profit 0.26 1.10 0.09 21.32 1.40
Selling/General/Admin. Expenses, Total 7.25 7.26 7.39 5.22 6.36
Research & Development 14.01 13.95 11.62 14.08 14.47
Depreciation/Amortization 0.00 0.17 0.17 0.17 0.18
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.00 0.00 0.00 4.67 1.67
Other Operating Expenses, Total - - - - -
Total Operating Expense 23.38 22.22 20.57 24.79 23.46
Operating Income -21.00 -20.28 -19.09 -2.81 -21.27
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 0.03 0.30 0.07 -0.06 0.09
Income Before Tax -18.88 -21.28 -15.52 -22.10 -26.58
Income After Tax -18.88 -21.28 -15.52 -22.10 -26.58
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -18.88 -21.28 -15.52 -22.10 -26.58
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -18.88 -21.28 -15.52 -22.10 -26.58
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -18.88 -21.28 -15.52 -22.10 -29.40
Income Available to Common Incl. Extra Items -18.88 -21.28 -15.52 -22.10 -29.40
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 0.00 0.00 0.00 0.00
Diluted Weighted Average Shares 217.50 217.31 213.88 190.27 164.21
Diluted EPS Excluding Extraordinary Items -0.09 -0.10 -0.07 -0.12 -0.18
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.09 -0.10 -0.07 -0.09 -0.17